Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CellCeuticals Skin Care is a dermatological company focused on the development of advanced cosmeceutical products that target skin aging at the cellular level. The company was co-founded by Paul Scott Premo and Dr. Garth Fisher, a prominent plastic surgeon, to bridge the gap between prescription-strength treatments and over-the-counter skincare. Their product line features proprietary technologies such as CellGenesis and NeoCell, which are designed to stimulate cellular regeneration and improve skin texture and tone. In January 2012, the assets of CellCeuticals were acquired by Valeant Pharmaceuticals, which is now known as Bausch Health. This acquisition allowed the brand's high-performance anti-aging treatments to be integrated into a broader portfolio of dermatological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CellCeuticals Skin Care.